Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 30, 2013
Jeffrey Bluestone, PhD, executive vice chancellor and provost, talks about how UC San Francisco is driving the field of precision medicine. This field promises to harness the vast advances in technology, genetics and biomedical research to understand the roots of disease, develop targeted therapies, and ultimately provide personal, predictive and preventive care to patients worldwide. "Today, we diagnose diabetes based on signs and symptoms, such as high blood sugar, and we treat people with the medication that works for some, but not all, patients. The promise of precision medicine is that one day we would be able to exactly identify the molecular basis of diseases such as diabetes in each individual and then identify the best therapy with the fewest side effects for an individual patient. For anyone who has lived with diabetes, that is an exciting concept."